Navigation Links
Need for federal protection against genetic discrimination
Date:3/24/2008

Washington A policy monograph highlighting the need for federal protections against genetic discrimination in employment and insurance practices was released today by the American College of Physicians (ACP). The six policy positions ACP believes should be included in the federal protections are the focus of the policy paper. http://www.acponline.org/advocacy/where_we_stand/policy/index.html.

While theyre not quite there, Congress does continue to move closer to passing federal legislation that protects the use of genetic information in employment and insurance coverage decisions, noted David C. Dale, MD, FACP president of the 125,000 member ACP. This monograph is important for the ongoing discussion.

ACPs first two positions consider insurance providers:

Position 1: Insurance providers should be prohibited from using an individuals genetic information to deny or limit health coverage or establish eligibility, enrollment, or premium contribution requirements.

Position 2: Insurance providers should be prohibited from establishing differential premiums based on an individuals genetic information or request for genetic screening.

ACPs policy positions result from a March 2007 survey conducted by the John Hopkins Genetics and Public Policy Center. It found that 86 percent of patients trust their physicians and 66 percent of patients trust genetic researchers with access to their genetic information. However, most people do not trust health insurers and employers not to misuse their genetic information through disclosure or discriminatory practices- should they have access to it.

The Colleges third position says:

Position 3: Employers should be prohibited from using an individuals genetic information in employment decisions, such as hiring, promoting, or terminating an employee or establishing the terms, conditions, and benefits or employment.

The ACP research looked at a report done by the National Partnership for Women and Families on behalf of the Coalition for Genetic Fairness that documents how fears of genetic discrimination negatively impact patient health care and financial well-being, public health, and scientific advancements. Examples include shielding genetic information from health care providers, refusing genetic testing, or undergoing testing using an alias.

Two more ACP positions which consider insurers and employers are:

Position 4: Insurers and employers should be prohibited from requiring individuals and families to undergo genetic testing

Position 5: Insurers and employers should be prohibited from collecting and/or disclosing an individual or familys genetic information. Written and informed consent should be required for each disclosure of genetic information and should include to whom the disclosure is made.

Finally, ACP considered specific Congressional considerations:

Position 6: Congress should establish comprehensive and uniform federal protection against genetic discrimination that closes the gaps in protection due to varying state laws. Federal protection should also cover ERISA health plans.


'/>"/>

Contact: David Kinsman
dkinsman@acponline.org
202-261-4554
American College of Physicians
Source:Eurekalert

Related biology news :

1. SNM applauds NAS study showing need to restore federal nuclear medicine research funding
2. NOAA proposes federal regulations to protect black abalone
3. 2 federal public health grants awarded to Weill Cornell Medical College
4. $13 million federal grant for research into vascular disease awarded to Weill Cornell
5. HR Initiative Endorses Bill to Create an Effective, Mandatory Federal Employment Verification System
6. Poll Shows Strong Doubts About Effectiveness of Federal Employment Verification System
7. Rain forest protection works in Peru
8. Antioxidants could provide all-purpose radiation protection
9. Secure Services Corp. Achieves Milestone in United States Identity Protection with the Launch of the SSC SHAPE Card Management Solution
10. Better protection for biomedial devices could result from Rutgers-Camden research
11. A search for protection against chemotherapy cardiotoxicity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/21/2016)... , June 21, 2016 NuData Security announced ... new role of principal product architect and that ... director of customer development. Both will report directly ... officer. The moves reflect NuData,s strategic growth in ... to high customer demand and customer focus values. ...
(Date:6/15/2016)... , June 15, 2016 ... market report titled "Gesture Recognition Market by Application Market - Global ... 2016 - 2024". According to the report, the  global ... billion in 2015 and is estimated to grow ... 48.56 billion by 2024.  Increasing application ...
(Date:6/7/2016)... TORONTO , June 7, 2016  Syngrafii ... begun a business relationship that includes integrating Syngrafii,s ... pilot branch project. This collaboration will result in ... for the credit union, while maintaining existing document ... http://photos.prnewswire.com/prnh/20160606/375871LOGO ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... , June 27, 2016  Sequenom, Inc. (NASDAQ: ... to enabling healthier lives through the development of innovative ... of the United States denied ... that the claims of Sequenom,s U.S. Patent No. 6,258,540 ... eligibility criteria established by the Supreme Court,s Mayo Collaborative ...
(Date:6/27/2016)... 27, 2016  Liquid Biotech USA ... of a Sponsored Research Agreement with The University ... (CTCs) from cancer patients.  The funding will be ... correlate with clinical outcomes in cancer patients undergoing ... then be employed to support the design of ...
(Date:6/24/2016)... ... , ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical ... mesothelioma. Their findings are the subject of a new article on the Surviving Mesothelioma ... in the blood, lung fluid or tissue of mesothelioma patients that can help point ...
(Date:6/23/2016)... 23, 2016 A person commits a crime, and ... to track the criminal down. An outbreak of ... Drug Administration (FDA) uses DNA evidence to track down the ... Sound far-fetched? It,s not. The FDA has increasingly used a ... of foodborne illnesses. Put as simply as possible, whole genome ...
Breaking Biology Technology: